SCHEMBL3936464

SCHEMBL3936464

Oc1cccc(P(C2CCCCC2)C2CCCCC2)c1-c1c(O)cccc1P(C1CCCCC1)C1CCCCC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
PPIA P62937 1/20 0.34
ALDH1A1 P00352 5/20 0.33
ALOX15 P16050 4/20 0.33
LMNA P02545 3/20 0.33
HPGD P15428 3/20 0.33
HTT P42858 2/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
HSD17B10 Q99714 3/20 0.32
TDP1 Q9NUW8 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16104888 0.86 DDB1 (0.35) ROCK2HDAC4HDAC2HDAC8PPIA
SCHEMBL10768611 0.85 ALDH1A1 (0.39) ROCK2HDAC4HDAC2HDAC8PPIA
SCHEMBL2318542 0.79 KMT2A (0.38) PPIAALDH1A1ALOX15LMNAHPGD
SCHEMBL205843 0.78 ROCK2 (0.38) ROCK2ALDH1A1LMNANPC1RAB9A
SCHEMBL1315359 0.78 ROCK2 (0.35) ROCK2ALDH1A1ALOX15LMNAHPGD
SCHEMBL12128642 0.77 TRIM24 (0.39) PPIAALDH1A1ALOX15LMNAHPGD
SCHEMBL11996804 0.77 MEN1 (0.49) ALDH1A1ALOX15LMNAHPGDKDM4E
SCHEMBL8963331 0.76 ROCK2 (0.38) ROCK2ALDH1A1LMNANPC1RAB9A
SCHEMBL1314189 0.75 ROCK2 (0.33) ROCK2ALDH1A1KDM4EHSD17B10
SCHEMBL17583591 0.74 ROCK2 (0.33) ROCK2KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1409493-B1 METHOD FOR PRODUCING NON-CHIRAL ORGANIC COMPOUNDS CONTAINING OPTICALLY ACTIVE HYDROXY GROUPS ARLT DIETER (DE) 2009-04-15 EP disclosed
US-6787676-B2 REACTING A CARBONYL COMPOUND WITH HYDROGEN IN THE PRESENCE OF A CATALYST, A BASE AND OPTIONALLY A DIAMINE, WHERE THE CATALYST IS A SUPPORT-BONDED RUTHENIUM(II) COMPLEX BISPHOSPHINE LIGAND AND A DIAMINE LIGAND STUDIENGESELLSCHAFT KOHLE MBH (DE) 2004-09-07 US disclosed
EP-1409493-A1 METHOD FOR PRODUCING NON-CHIRAL ORGANIC COMPOUNDS CONTAINING OPTICALLY ACTIVE HYDROXY GROUPS Studiengesellschaft Kohle mbH (DE) 2004-04-21 EP disclosed
WO-2002076997-A1 METHOD FOR PRODUCING NON-CHIRAL ORGANIC COMPOUNDS CONTAINING OPTICALLY ACTIVE HYDROXY GROUPS LIGAND CHEMIE GMBH (DE) 2002-10-03 WO disclosed
US-20020111515-A1 Reacting a carbonyl compound with hydrogen in the presence of a catalyst, a base and optionally a diamine, where the catalyst is a support-bonded ruthenium(II) complex bisphosphine ligand and a diamine ligand STUDIENGESELLSCHAFT KOHLE MBH (DE) 2002-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020111515-A1 Reacting a carbonyl compound with hydrogen in the presence of a catalyst, a base and optionally a diamine, where the catalyst is a support-bonded ruthenium(II) complex bisphosphine ligand and a diamine ligand PDK1, ADH1A, HRH3 ROCK2 2062/4885HDAC4 2934/4885HDAC2 1811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.